https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
133
 
downloads
21
CITE
How to cite this poster:
Kori S, Zhang J, Kellerman D et al. Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors. F1000Posters 2012, 3:1016 (poster)

Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors

Shashidar Kori1, Jian Zhang, Donald Kellerman, Tom Armer, Peter J Goadsby
Published 24 Aug 2012
Author Affiliations
  • Metrics
  • 133 Views
  • 21 Downloads
Browse by related subjects
Published 24 Aug 2012

Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors

[version 1; not peer reviewed]

Shashidar Kori1, Jian Zhang, Donald Kellerman, Tom Armer, Peter J Goadsby
Author Affiliations
1 Medical Affairs, MAP Pharmaceuticals, Inc., USA
Presented at
54th American Headache Society Annual Meeting 2012
Abstract
Competing Interests

All the authors are paid employees of MAP Pharmaceuticals, Inc. and the study was funded by MAP Pharmaceuticals, Inc.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.